Abstract
The race between the public (International Human Genome Consortium) and private (Celera) efforts to sequence the human genome was relatively fierce by scientific standards. But as last month's publications in Science and Nature show, the two groups crossed the finishing line together. Nature Medicine talked to the man who, as part of the Consortium, lead the Sanger Centre in Cambridge, UK, through this historical time to sequence the second largest part of the genome outside the US.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
